IL206819A0 - Pyrrolopyrimidines and pyrrolopyridines - Google Patents

Pyrrolopyrimidines and pyrrolopyridines

Info

Publication number: IL206819A0
Authority: IL; Israel
Prior art keywords: pyrrolopyridines; pyrrolopyrimidines
Prior art date: 2008-01-11

Application number

IL206819A

Other languages

English (en)

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-01-11

Filing date

2010-07-05

Publication date

2010-12-30

2010-07-05 Application filed by Novartis Ag filed Critical Novartis Ag

2010-12-30 Publication of IL206819A0 publication Critical patent/IL206819A0/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Virology (AREA)
Orthopedic Medicine & Surgery (AREA)
Heart & Thoracic Surgery (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Dermatology (AREA)
Oncology (AREA)
Neurology (AREA)
Urology & Nephrology (AREA)
Neurosurgery (AREA)
Ophthalmology & Optometry (AREA)
Biomedical Technology (AREA)
Hospice & Palliative Care (AREA)
Biotechnology (AREA)
Gastroenterology & Hepatology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IL206819A 2008-01-11 2010-07-05 Pyrrolopyrimidines and pyrrolopyridines IL206819A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP08150182		2008-01-11
PCT/EP2009/050225 WO2009087225A2 (en)	2008-01-11	2009-01-09	Pyrrolopyrimidines and pyrrolopyridines

Publications (1)

Publication Number	Publication Date
IL206819A0 true IL206819A0 (en)	2010-12-30

Family

ID=39445770

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL206819A IL206819A0 (en)	2008-01-11	2010-07-05	Pyrrolopyrimidines and pyrrolopyridines

Country Status (22)

Country	Link
US (1)	US8314112B2 (es)
EP (1)	EP2242756A2 (es)
JP (1)	JP5643110B2 (es)
KR (1)	KR20100116606A (es)
CN (1)	CN101970435B (es)
AR (1)	AR070127A1 (es)
AU (1)	AU2009203694B2 (es)
BR (1)	BRPI0907231A2 (es)
CA (1)	CA2711845A1 (es)
CL (1)	CL2009000028A1 (es)
CO (1)	CO6331340A2 (es)
CR (1)	CR11554A (es)
EA (1)	EA201001126A1 (es)
EC (1)	ECSP10010335A (es)
IL (1)	IL206819A0 (es)
MA (1)	MA31952B1 (es)
MX (1)	MX2010007605A (es)
PE (1)	PE20091306A1 (es)
TN (1)	TN2010000305A1 (es)
TW (1)	TW200934781A (es)
WO (1)	WO2009087225A2 (es)
ZA (1)	ZA201004602B (es)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CL2007003444A1 (es) *	2006-11-30	2008-06-27	Genentech Inc	Compuestos derivados de pirrolo[3,2-c]piridina; composicion farmaceutica; y uso en el tratamiento de un trastorno hiperproliferativo o una enfermedad inflamatoria.
MX2010006457A (es)	2007-12-19	2010-07-05	Amgen Inc	Compuestos fusionados de piridina, pirimidina y triazina como inhibidores de ciclo celular.
JP5530422B2 (ja)	2008-04-07	2014-06-25	アムジエン・インコーポレーテツド	細胞周期阻害薬としてのｇｅｍ−二置換およびスピロ環式アミノピリジン／ピリミジン
US9273077B2 (en)	2008-05-21	2016-03-01	Ariad Pharmaceuticals, Inc.	Phosphorus derivatives as kinase inhibitors
WO2009143389A1 (en)	2008-05-21	2009-11-26	Ariad Pharmaceuticals, Inc.	Phosphorous derivatives as kinase inhibitors
CA2676946A1 (en)	2009-08-28	2011-02-28	Lucie Peduto	Adam12 inhibitors and their use against inflammation-induced fibrosis
EP2475666A2 (en) *	2009-09-11	2012-07-18	Trius Therapeutics, Inc.	Gyrase inhibitors
SG182803A1 (en) *	2010-02-05	2012-09-27	Merck Patent Gmbh	Hetaryl-[1,8]naphthyridine derivatives
US8815893B2 (en)	2010-02-22	2014-08-26	Merck Patent Gmbh	Hetarylaminonaphthyridines
EP2539338A1 (en) *	2010-02-24	2013-01-02	Syngenta Participations AG	Novel microbicides
AU2011272198B2 (en)	2010-06-30	2016-09-22	Fujifilm Corporation	Novel nicotinamide derivatives or salts thereof
PT2624696T (pt)	2010-10-06	2017-03-21	Glaxosmithkline Llc	Derivados de benzimidazole como inibidores da cinase pi3
CN103703000B (zh)	2011-03-23	2015-11-25	安姆根有限公司	Cdk4/6和flt3的稠合三环双重抑制剂
CN103501612B (zh)	2011-05-04	2017-03-29	阿里亚德医药股份有限公司	抑制表皮生长因子受体导致的癌症中细胞增殖的化合物
CN103635189B (zh)	2011-07-01	2016-05-04	诺华股份有限公司	用于治疗癌症的含有cdk4/6抑制剂和pi3k抑制剂的联合治疗
EP2573086A1 (en) *	2011-09-26	2013-03-27	AiCuris GmbH & Co. KG	N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate
EP2573085A1 (en)	2011-09-26	2013-03-27	AiCuris GmbH & Co. KG	N-[5-(aminosulfonyl)-4methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl] acetamide mesylate monohydrate having a specific particle size distribution range and a specific surface area range
JP6469567B2 (ja)	2012-05-05	2019-02-13	アリアド・ファーマシューティカルズ・インコーポレイテッド	Ｅｇｆｒ発動性がんの細胞増殖阻害用化合物
JO3407B1 (ar)	2012-05-31	2019-10-20	Eisai R&D Man Co Ltd	مركبات رباعي هيدرو بيرازولو بيريميدين
AR091271A1 (es)	2012-06-07	2015-01-21	Hoffmann La Roche	Pirrolopirimidona y pirrolopiridona, inhibidores de tanquirasa
US9353107B2 (en) *	2012-07-03	2016-05-31	Aurigene Discovery Technologies Limited	3-(pyrazolyl)-1H-pyrrolo[2,3-b]pyridine derivatives as kinase inhibitors
US9682983B2 (en)	2013-03-14	2017-06-20	The Brigham And Women's Hospital, Inc.	BMP inhibitors and methods of use thereof
US9611283B1 (en)	2013-04-10	2017-04-04	Ariad Pharmaceuticals, Inc.	Methods for inhibiting cell proliferation in ALK-driven cancers
CN105339368B (zh)	2013-06-04	2017-08-15	拜耳制药股份公司	3‑芳基‑取代的咪唑并[1,2‑a]吡啶及其用途
WO2015124544A1 (de)	2014-02-19	2015-08-27	Bayer Pharma Aktiengesellschaft	3-(pyrimidin-2-yl)imidazo[1,2-a]pyridine
EP3122355A4 (en) *	2014-03-26	2017-08-09	The Brigham and Women's Hospital, Inc.	Compositions and methods for inhibiting bmp
TW201613916A (en)	2014-06-03	2016-04-16	Gilead Sciences Inc	TANK-binding kinase inhibitor compounds
US10513521B2 (en)	2014-07-15	2019-12-24	The Brigham And Women's Hospital, Inc.	Compositions and methods for inhibiting BMP
EP3517536B1 (en)	2014-09-26	2021-05-05	Gilead Sciences, Inc.	Aminotriazine derivatives useful as tank-binding kinase inhibitor compounds
EP3227287B1 (de)	2014-12-02	2019-08-07	Bayer Pharma Aktiengesellschaft	Heteroaryl-substituierte imidazo[1,2-a]pyridine und ihre verwendung
US10526287B2 (en)	2015-04-23	2020-01-07	Constellation Pharmaceuticals, Inc.	LSD1 inhibitors and uses thereof
WO2016183071A1 (en)	2015-05-11	2016-11-17	Incyte Corporation	Hetero-tricyclic compounds and their use for the treatment of cancer
US9708333B2 (en)	2015-08-12	2017-07-18	Incyte Corporation	Fused bicyclic 1,2,4-triazine compounds as TAM inhibitors
US10053465B2 (en)	2015-08-26	2018-08-21	Incyte Corporation	Pyrrolopyrimidine derivatives as TAM inhibitors
FR3041640B1 (fr)	2015-09-30	2019-05-17	Les Laboratoires Servier	NOUVEAUX DERIVES DE PYRROLO[2,3-d]PYRIMIDINE, LEUR PROCEDE DE PREPRATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT
MX2018007421A (es)	2015-12-17	2018-08-15	Gilead Sciences Inc	Compuestos inhibidores de quinasa de union a tank.
CN109311868B (zh)	2015-12-22	2022-04-01	尚医治疗有限责任公司	用于治疗癌症和炎性疾病的化合物
TWI753892B (zh)	2016-03-28	2022-02-01	美商英塞特公司	作為ｔａｍ抑制劑之吡咯并三嗪化合物
SG11201808907PA (en)	2016-04-15	2018-11-29	Blueprint Medicines Corp	Inhibitors of activin receptor-like kinase
EP3532459B1 (en)	2016-10-26	2023-08-02	Constellation Pharmaceuticals, Inc.	Lsd1 inhibitors and medical uses thereof
IL271230B2 (en)	2017-06-21	2024-06-01	SHY Therapeutics LLC	Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
CN109384782A (zh) *	2017-08-04	2019-02-26	厦门大学	取代五元并六元杂环类化合物、其制备方法、药物组合及其用途
MA50655B1 (fr)	2017-09-27	2021-11-30	Incyte Corp	Sels de dérivés de pyrrolotriazine utiles en tant qu'inhibiteurs de tam
US11236086B2 (en)	2017-10-18	2022-02-01	Blueprint Medicines Corporation	Substituted pyrrolopyridines as inhibitors of activin receptor-like kinase
CA3085460A1 (en) *	2017-12-22	2019-06-27	Petra Pharma Corporation	Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors
US12303498B2 (en) *	2018-03-23	2025-05-20	Cytoo	ALK5 inhibitors as skeletal muscle hypertrophy inducers
MD3813800T2 (ro)	2018-06-29	2025-10-31	Incyte Corp	Formulări de inhibitor al AXL/MER
WO2020012357A1 (en) *	2018-07-10	2020-01-16	Integral Biosciences Pvt. Ltd.	Heterocyclic compounds and methods of use
CN111018858B (zh) *	2018-10-10	2022-11-18	复旦大学	杂环类衍生物及其制备方法和用途
TWI827760B (zh) *	2018-12-12	2024-01-01	加拿大商愛彼特生物製藥公司	經取代之芳基甲基脲類及雜芳基甲基脲類、其類似物及其使用方法
JP7407461B2 (ja)	2018-12-19	2024-01-04	シャイ・セラピューティクス・エルエルシー	がん、炎症性疾患、ｒａｓ病、及び線維性疾患の処置のためのｒａｓスーパーファミリーと相互作用する化合物
KR20200105246A (ko) *	2019-02-28	2020-09-07	한미약품 주식회사	아데노신 수용체 길항제로서 신규 화합물 및 이를 포함하는 약학 조성물
CN115697343A (zh)	2020-03-06	2023-02-03	因赛特公司	包含axl/mer和pd-1/pd-l1抑制剂的组合疗法
CA3171774C (en) *	2020-03-16	2025-05-20	Shanghai Haiyan Pharmaceutical Technology Co., Ltd.	AMINE DERIVATIVE PYRIMIDINE OR SUBSTITUTED PYRIDINE, RELATED COMPOSITION AND RELATED MEDICAL USE
CN113698395B (zh) *	2020-05-22	2023-12-08	赛诺哈勃药业（成都）有限公司	转化生长因子受体拮抗剂、其制备方法和应用
BR112022024729A2 (pt)	2020-06-05	2023-02-28	Kinnate Biopharma Inc	Inibidores de quinases do receptor do fator de crescimento de fibroblastos
FI4182308T3 (fi)	2020-07-15	2024-12-07	Chiesi Farm Spa	Pyridatsinyyliaminojohdannaisia alk5-estäjinä
US20240190891A1 (en)	2020-07-15	2024-06-13	Chiesi Farmaceutici S.P.A.	Pyrido oxazine amino derivatives as alk5 inhibitors
WO2022013311A1 (en)	2020-07-15	2022-01-20	Chiesi Farmaceutici S.P.A.	Pyrido oxazine derivatives as alk5 inhibitors
WO2022136221A1 (en)	2020-12-23	2022-06-30	Chiesi Farmaceutici S.P.A.	Pyrido oxazine derivatives as alk5 inhibitors
CN118201915A (zh)	2021-09-21	2024-06-14	奇斯药制品公司	作为alk5抑制剂的哒嗪基氨基衍生物
WO2023208986A1 (en)	2022-04-27	2023-11-02	Chiesi Farmaceutici S.P.A.	Imidazole derivatives as alk5 inhibitors
CN118126036A (zh) *	2022-12-01	2024-06-04	复旦大学	7-氮杂吲哚类化合物及其制备方法和应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HUT70954A (en)	1992-04-03	1995-11-28	Upjohn Co	Bicyclic-heterocyclic amines containing nitrogen heteroatoms
US6686366B1 (en) *	1998-06-02	2004-02-03	Osi Pharmaceuticals, Inc.	Compounds specific to adenosine A3 receptor and uses thereof
JP2002540206A (ja) *	1999-03-11	2002-11-26	ニューロゲンコーポレイション	アリールの縮合した２，４−二置換ピリジン：ｎｋ３受容体リガンド
AU784878B2 (en)	1999-12-02	2006-07-13	Osi Pharmaceuticals, Inc.	Compounds specific to adenosine A1 A2A and A3 receptors and uses thereof
US7160890B2 (en)	1999-12-02	2007-01-09	Osi Pharmaceuticals, Inc.	Compounds specific to adenosine A3 receptor and uses thereof
US6680322B2 (en)	1999-12-02	2004-01-20	Osi Pharmaceuticals, Inc.	Compounds specific to adenosine A1 receptors and uses thereof
MXPA03004717A (es)	2000-12-01	2004-06-30	Osi Pharm Inc	Compuestos especificos para el receptor a1, a2 y a3 de adenosina y usos de los mismos.
US6680324B2 (en)	2000-12-01	2004-01-20	Osi Pharmaceuticals, Inc.	Compounds specific to adenosine A1 receptors and uses thereof
US6673802B2 (en)	2000-12-01	2004-01-06	Osi Pharmaceuticals, Inc.	Compounds specific to adenosine A3 receptor and uses thereof
GB0100622D0 (en)	2001-01-10	2001-02-21	Vernalis Res Ltd	Chemical compounds V111
EP1450811B1 (en)	2001-11-30	2009-10-21	OSI Pharmaceuticals, Inc.	Compounds specific to adenosine A1 and A3 receptors and uses thereof
US20030139427A1 (en) *	2002-08-23	2003-07-24	Osi Pharmaceuticals Inc.	Bicyclic pyrimidinyl derivatives and methods of use thereof
WO2004065392A1 (en) *	2003-01-24	2004-08-05	Smithkline Beecham Corporation	Condensed pyridines and pyrimidines and their use as alk-5 receptor ligands
EP1603908B1 (en) *	2003-03-12	2008-06-11	Millennium Pharmaceuticals, Inc.	Quinazoline derivatives as tgf-beta inhibitors
US20050205625A1 (en) *	2004-03-16	2005-09-22	House Arthur G	Container support device, system, and method
DE602006013792D1 (de)	2005-02-18	2010-06-02	Solvay Pharm Gmbh	Pharmazeutische zusammensetzungen mit nep-inhibitoren, inhibitoren des endogenes endothelin produzierenden systems und diuretika
US20060205625A1 (en)	2005-02-18	2006-09-14	Solvay Pharmaceuticals Gmbh	Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics
US20070014956A1 (en) *	2005-07-14	2007-01-18	Mccarthy Dillon P	Adhesive tape device
WO2007076348A2 (en) *	2005-12-23	2007-07-05	Smithkline Beecham Corporation	Azaindole inhibitors of aurora kinases

2009
- 2009-01-08 AR ARP090100050A patent/AR070127A1/es not_active Application Discontinuation
- 2009-01-09 US US12/351,438 patent/US8314112B2/en not_active Expired - Fee Related
- 2009-01-09 CN CN200980108446.3A patent/CN101970435B/zh not_active Expired - Fee Related
- 2009-01-09 TW TW098100815A patent/TW200934781A/zh unknown
- 2009-01-09 EP EP20090700871 patent/EP2242756A2/en not_active Withdrawn
- 2009-01-09 WO PCT/EP2009/050225 patent/WO2009087225A2/en not_active Ceased
- 2009-01-09 PE PE2009000024A patent/PE20091306A1/es not_active Application Discontinuation
- 2009-01-09 EA EA201001126A patent/EA201001126A1/ru unknown
- 2009-01-09 JP JP2010541794A patent/JP5643110B2/ja not_active Expired - Fee Related
- 2009-01-09 CA CA2711845A patent/CA2711845A1/en not_active Abandoned
- 2009-01-09 MX MX2010007605A patent/MX2010007605A/es active IP Right Grant
- 2009-01-09 BR BRPI0907231A patent/BRPI0907231A2/pt not_active IP Right Cessation
- 2009-01-09 KR KR1020107017744A patent/KR20100116606A/ko not_active Withdrawn
- 2009-01-09 CL CL2009000028A patent/CL2009000028A1/es unknown
- 2009-01-09 AU AU2009203694A patent/AU2009203694B2/en not_active Ceased
2010
- 2010-06-30 MA MA32971A patent/MA31952B1/fr unknown
- 2010-06-30 ZA ZA2010/04602A patent/ZA201004602B/en unknown
- 2010-06-30 TN TN2010000305A patent/TN2010000305A1/fr unknown
- 2010-07-02 CR CR11554A patent/CR11554A/es not_active Application Discontinuation
- 2010-07-05 IL IL206819A patent/IL206819A0/en unknown
- 2010-07-09 EC EC2010010335A patent/ECSP10010335A/es unknown
- 2010-07-12 CO CO10084491A patent/CO6331340A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
US20090181941A1 (en)	2009-07-16
PE20091306A1 (es)	2009-09-24
AU2009203694A1 (en)	2009-07-16
TN2010000305A1 (en)	2011-11-11
ECSP10010335A (es)	2010-08-31
CR11554A (es)	2010-08-11
ZA201004602B (en)	2011-03-30
CA2711845A1 (en)	2009-07-16
KR20100116606A (ko)	2010-11-01
EA201001126A1 (ru)	2011-02-28
CL2009000028A1 (es)	2009-07-17
WO2009087225A3 (en)	2009-11-05
JP5643110B2 (ja)	2014-12-17
US8314112B2 (en)	2012-11-20
WO2009087225A2 (en)	2009-07-16
BRPI0907231A2 (pt)	2019-09-24
TW200934781A (en)	2009-08-16
MA31952B1 (fr)	2010-12-01
JP2011509279A (ja)	2011-03-24
CN101970435A (zh)	2011-02-09
CO6331340A2 (es)	2011-10-20
AR070127A1 (es)	2010-03-17
AU2009203694B2 (en)	2012-04-26
CN101970435B (zh)	2014-07-02
EP2242756A2 (en)	2010-10-27
MX2010007605A (es)	2010-08-02

Publication	Publication Date	Title
IL206819A0 (en)	2010-12-30	Pyrrolopyrimidines and pyrrolopyridines
ZA201002334B (en)	2011-03-30	Imidazo
IL226486A0 (en)	2013-06-27	Converted pyrazolopyrimidine compounds
EP2056822A4 (en)	2009-09-16	SUBSTITUTED PYRROLOPYRIDINES AND PYRAZOLOPYRIDINES AS MODULATORS OF KINASE
GB0818241D0 (en)	2008-11-12	Compounds and their use
ZA201008295B (en)	2012-04-25	Improvements in feedwells
PL2344449T3 (pl)	2015-10-30	Związki arylo-fenylo-sulfonamido-cykloalkilowe i ich zastosowanie
IL208081A0 (en)	2010-12-30	Amido - thiophene compounds and their use
ZA201007395B (en)	2011-12-28	Aryl-quinolyl compounds and their use
GB0819280D0 (en)	2008-11-26	Imgaing and radiotherapy methods
PL2294024T3 (pl)	2013-08-30	Emalie i nośniki
ZA201104161B (en)	2016-05-25	Dihydroetorphines and their preparation
EP2343759A4 (en)	2012-05-30	BATTERY COMPONENT AND BATTERY
IL202285A0 (en)	2010-06-16	Macrocycles and their uses
GB0817940D0 (en)	2008-11-05	Colouring techniques
GB0801319D0 (en)	2008-03-05	Compounds and their use
EP2348865A4 (en)	2012-08-01	BETA-HYDROXY-GAMMA-AMINOPHOSPHONATES, THEIR METHODS OF PREPARATION AND THEIR USE
GB0813359D0 (en)	2008-08-27	Halfin and/or platerfin
GB0803082D0 (en)	2008-03-26	Method and kit
GB0707069D0 (en)	2007-05-23	Methods and uses
HK1144285A (en)	2011-02-11	Pyrrolopyrimidines and pyrrolopyridines
GB0823515D0 (en)	2009-01-28	Improvements in bivvies
IL191807A0 (en)	2009-05-04	Vehicle and vehicle components
GB0802195D0 (en)	2008-03-12	Compounds and their use II
GB0816523D0 (en)	2008-10-15	Methods and uses